HomeCompareGLPEY vs MRK

GLPEY vs MRK: Dividend Comparison 2026

GLPEY yields 3.10% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.1K in total portfolio value
10 years
GLPEY
GLPEY
● Live price
3.10%
Share price
$12.00
Annual div
$0.37
5Y div CAGR
-34.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$4.45
Full GLPEY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GLPEY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGLPEYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GLPEY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GLPEY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GLPEY
Annual income on $10K today (after 15% tax)
$263.69/yr
After 10yr DRIP, annual income (after tax)
$3.78/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,324.63/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GLPEY + MRK for your $10,000?

GLPEY: 50%MRK: 50%
100% MRK50/50100% GLPEY
Portfolio after 10yr
$38.7K
Annual income
$4,901.29/yr
Blended yield
12.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GLPEY
Analyst Ratings
1
Buy
2
Hold
1
Sell
Consensus: Hold
Altman Z
4.1
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GLPEY buys
0
MRK buys
0
No recent congressional trades found for GLPEY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGLPEYMRK
Forward yield3.10%2.76%
Annual dividend / share$0.37$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-34.9%32.7%
Portfolio after 10y$20.6K$56.8K
Annual income after 10y$4.45$9,798.13
Total dividends collected$582.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: GLPEY vs MRK ($10,000, DRIP)

YearGLPEY PortfolioGLPEY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,902$201.96$11,206$366.19$304.00MRK
2$11,799$133.96$12,650$502.35$851.00MRK
3$12,713$88.21$14,407$694.19$1.7KMRK
4$13,661$57.82$16,585$967.82$2.9KMRK
5$14,655$37.80$19,342$1,363.89$4.7KMRK
6$15,706$24.67$22,913$1,947.19$7.2KMRK
7$16,821$16.09$27,662$2,823.89$10.8KMRK
8$18,009$10.48$34,159$4,173.35$16.1KMRK
9$19,276$6.83$43,337$6,308.80$24.1KMRK
10$20,630$4.45$56,776$9,798.13$36.1KMRK

GLPEY vs MRK: Complete Analysis 2026

GLPEYStock

Galp Energia, SGPS, S.A. operates as an integrated energy operator in Portugal and internationally. The company operates through four segments: Upstream, Industrial & Energy Management, Commercial, and Renewables and New Business. The Upstream segment engages in the exploration, development, and production of hydrocarbons primarily in Brazil, Mozambique, and Angola. The Industrial & Energy Management segment owns refineries in Portugal, as well as is involved in activities related to energy management of oil products, gas, and electricity. This segment also provides storage and transportation infrastructure for oil and gas products, as well as engages in the sale of electricity to the grid in Portugal and Spain. The Commercial segment is involved in the areas of retail to final business-to-business and business to consumer customers of oil, gas, and electricity. The Renewables and New Business segment is involved in the development of solar and wind power generation projects in Portugal and Spain. In addition, it produces biodiesel, biofuel, and green hydrogen; and operates 1,480 service stations and 1,186 electric mobility charging points. Further, the company engages in the reinsurance business. The company was formerly known as Galp – Petróleos e Gás de Portugal, SGPS, S.A. and changed its name to Galp Energia, SGPS, S.A. in September 2000. Galp Energia, SGPS, S.A. was incorporated in 1999 and is headquartered in Lisbon, Portugal.

Full GLPEY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GLPEY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GLPEY vs SCHDGLPEY vs JEPIGLPEY vs OGLPEY vs KOGLPEY vs MAINGLPEY vs JNJGLPEY vs ABBVGLPEY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.